MedTrace Logo

Continuous Glucose Monitoring in Critically Ill Patients

NCT00494455 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2008-02-29

No results posted yet for this study

Summary

The purpose of this study is to determine whether subcutaneous continuous glucose monitoring in critically ill patients is clinically feasible accurate and reliable.

Conditions

  • Critical Illness

Interventions

DEVICE

continuous subcutaneous glucose monitoring

continuous subcutaneous glucose monitoring for 72h

DEVICE

continuous subcutaneous glucose monitoring

continuous subcutaneous glucose monitoring for 72h

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Ulrike Holzinger, MD · Medical University of Vienna, Department of Medicine III

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2006-04-30
Completion
2007-03-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00494455 on ClinicalTrials.gov